Applied Therapeutics, Inc. (APLT)

Data as of Feb 4, 2026, from SEC Form 4 filings.

No open-market insider trades (90d)Watch APLT

See up to 3 months of APLT. The 7-day demo opens the 1M and 3M ranges and puts APLT on your watchlist.

Latest APLT insider trades

Stacy J. Kanter
Open-market sale$5K
Dec 16, 2025
Stacy J. Kanter
Derivative22,500 sh
Feb 3, 2026
Stacy J. Kanter
Other42,500 sh

About Applied Therapeutics, Inc. (APLT)

The SEC lists Applied Therapeutics, Inc. under CIK 0001697532, in pharmaceutical preparations. It is grouped with Health Care companies on this site.

Sector: Health Care

SEC filings for APLT on EDGAR

APLT Form 4 activity by transaction type, last 90 days

No Form 4 activity for APLT in the last 90 days.

APLT insider transactions (Form 4)

14 Form 4 filings on record, the earliest from Dec 20, 2024, newest first.

Date	Insider	Transaction	Security	Shares	Price	Value
Feb 3, 2026	Stacy J. Kanter	Derivative	Common Stock	22,500	-^{footnote F1,F2}	-
Feb 3, 2026	Stacy J. Kanter	Other	Common Stock	42,500	-^{footnote F1,F3}	-
Feb 3, 2026	Stacy J. Kanter	Derivative	Stock Option (Right to Buy)	20,460	-^{footnote F4}	-
Feb 3, 2026	Stacy J. Kanter	Derivative	Stock Option (Right to Buy)	10,230	-^{footnote F4}	-
Feb 3, 2026	Stacy J. Kanter	Derivative	Stock Option (Right to Buy)	16,500	-^{footnote F4}	-
Feb 3, 2026	Stacy J. Kanter	Derivative	Stock Option (Right to Buy)	16,500	-^{footnote F4}	-
Feb 3, 2026	Stacy J. Kanter	Derivative	Stock Option (Right to Buy)	200,000	-^{footnote F4}	-
Footnote F1 (price): Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. ("Purchaser"), Purchaser completed a tender offer for shares of Issuer and thereafter merged… Full note on SEC EDGAR Footnote F2 (price): Pursuant to the Merger Agreement, at the Effective Time, each outstanding RSU (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive the Merger Consideration. Footnote F3 (price): Pursuant to the Merger Agreement, each share of common stock tendered by the Reporting Person was tendered in exchange for the Merger Consideration. Footnote F4 (price): Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a "Stock Option") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an… Full note on SEC EDGAR
Dec 19, 2025	Corwin Dale Hooks - Officer	Grant or award	Common Stock	312,500	$0.00	-
Feb 3, 2026	Corwin Dale Hooks - Officer	Derivative	Common Stock	862,500	-^{footnote F3,F4}	-
Feb 3, 2026	Corwin Dale Hooks - Officer	Other	Common Stock	5,753	-^{footnote F5}	-
Footnote F3 (price): Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. ("Purchaser"), Purchaser completed a tender offer for shares of Issuer and thereafter merged… Full note on SEC EDGAR Footnote F4 (price): Pursuant to the Merger Agreement, at the Effective Time, each outstanding RSU (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive the Merger Consideration. Footnote F5 (price): Pursuant to the Merger Agreement, each share of common stock tendered by the Reporting Person was tendered in exchange for the Merger Consideration.
Dec 19, 2025	Constantine Chinoporos - Officer	Grant or award	Common Stock	437,500	$0.00	-
Feb 3, 2026	Constantine Chinoporos - Officer	Derivative	Common Stock	1,000,000	-^{footnote F3,F4}	-
Feb 3, 2026	Constantine Chinoporos - Officer	Other	Common Stock	57,111	-^{footnote F5}	-
Footnote F3 (price): Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. ("Purchaser"), Purchaser completed a tender offer for shares of Issuer and thereafter merged… Full note on SEC EDGAR Footnote F4 (price): Pursuant to the Merger Agreement, at the Effective Time, each outstanding RSU (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive the Merger Consideration. Footnote F5 (price): Pursuant to the Merger Agreement, each share of common stock tendered by the Reporting Person was tendered in exchange for the Merger Consideration.
Feb 3, 2026	Jay S. Skyler	Derivative	Stock Option (Right to Buy)	16,500	-^{footnote F4}	-
Feb 3, 2026	Jay S. Skyler	Derivative	Stock Option (Right to Buy)	16,500	-^{footnote F4}	-
Feb 3, 2026	Jay S. Skyler	Derivative	Common Stock	22,500	-^{footnote F1,F2}	-
Feb 3, 2026	Jay S. Skyler	Other	Common Stock	42,500	-^{footnote F1,F3}	-
Feb 3, 2026	Jay S. Skyler	Derivative	Stock Option (Right to Buy)	20,460	-^{footnote F4}	-
Feb 3, 2026	Jay S. Skyler	Derivative	Stock Option (Right to Buy)	10,230	-^{footnote F4}	-
Feb 3, 2026	Jay S. Skyler	Derivative	Stock Option (Right to Buy)	200,000	-^{footnote F4}	-
Footnote F1 (price): Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. ("Purchaser"), Purchaser completed a tender offer for shares of Issuer and thereafter merged… Full note on SEC EDGAR Footnote F2 (price): Pursuant to the Merger Agreement, at the Effective Time, each outstanding RSU (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive the Merger Consideration. Footnote F3 (price): Pursuant to the Merger Agreement, each share of common stock tendered by the Reporting Person was tendered in exchange for the Merger Consideration. Footnote F4 (price): Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a "Stock Option") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an… Full note on SEC EDGAR
Dec 19, 2025	Leslie D. Funtleyder - Officer	Grant or award	Common Stock	1,187,500	$0.00	-
Feb 3, 2026	Leslie D. Funtleyder - Officer	Derivative	Common Stock	2,375,000	-^{footnote F2,F3}	-
Feb 3, 2026	Leslie D. Funtleyder - Officer	Other	Common Stock	152,959	-^{footnote F4}	-
Feb 3, 2026	Leslie D. Funtleyder - Officer	Derivative	Stock Option (Right to Buy)	20,460	-^{footnote F5}	-
Feb 3, 2026	Leslie D. Funtleyder - Officer	Derivative	Stock Option (Right to Buy)	10,230	-^{footnote F5}	-
Feb 3, 2026	Leslie D. Funtleyder - Officer	Derivative	Stock Option (Right to Buy)	16,500	-^{footnote F5}	-
Feb 3, 2026	Leslie D. Funtleyder - Officer	Derivative	Stock Option (Right to Buy)	16,500	-^{footnote F5}	-
Feb 3, 2026	Leslie D. Funtleyder - Officer	Derivative	Stock Option (Right to Buy)	150,000	-^{footnote F5}	-
Feb 3, 2026	Leslie D. Funtleyder - Officer	Derivative	Stock Option (Right to Buy)	40,502	-^{footnote F5}	-
Footnote F2 (price): Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. ("Purchaser"), Purchaser completed a tender offer for shares of Issuer and thereafter merged… Full note on SEC EDGAR Footnote F3 (price): Pursuant to the Merger Agreement, at the Effective Time, each outstanding RSU (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive the Merger Consideration. Footnote F4 (price): Pursuant to the Merger Agreement, each share of common stock tendered by the Reporting Person was tendered in exchange for the Merger Consideration. Footnote F5 (price): Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a "Stock Option") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an… Full note on SEC EDGAR
Dec 19, 2025	Evan Prescott Bailey - Officer	Grant or award	Common Stock	437,500	$0.00	-
Feb 3, 2026	Evan Prescott Bailey - Officer	Derivative	Common Stock	1,235,915	-^{footnote F3,F4}	-
Feb 3, 2026	Evan Prescott Bailey - Officer	Other	Common Stock	60,901	-^{footnote F5}	-
Feb 3, 2026	Evan Prescott Bailey - Officer	Derivative	Stock Option (Right to Buy)	19,531	-^{footnote F6}	-
Feb 3, 2026	Evan Prescott Bailey - Officer	Derivative	Stock Option (Right to Buy)	4,883	-^{footnote F6}	-
Footnote F3 (price): Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. ("Purchaser"), Purchaser completed a tender offer for shares of Issuer and thereafter merged… Full note on SEC EDGAR Footnote F4 (price): Pursuant to the Merger Agreement, at the Effective Time, each outstanding RSU (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive the Merger Consideration. Footnote F5 (price): Pursuant to the Merger Agreement, each share of common stock tendered by the Reporting Person was tendered in exchange for the Merger Consideration. Footnote F6 (price): Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a "Stock Option") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an… Full note on SEC EDGAR
Feb 3, 2026	Teena Lerner	Derivative	Stock Option (Right to Buy)	16,500	-^{footnote F4}	-
Feb 3, 2026	Teena Lerner	Derivative	Stock Option (Right to Buy)	200,000	-^{footnote F4}	-
Feb 3, 2026	Teena Lerner	Derivative	Stock Option (Right to Buy)	23,941	-^{footnote F4}	-
Feb 3, 2026	Teena Lerner	Derivative	Common Stock	22,500	-^{footnote F1,F2}	-
Feb 3, 2026	Teena Lerner	Other	Common Stock	82,922	-^{footnote F1,F3}	-
Feb 3, 2026	Teena Lerner	Derivative	Stock Option (Right to Buy)	20,460	-^{footnote F4}	-
Feb 3, 2026	Teena Lerner	Derivative	Stock Option (Right to Buy)	10,230	-^{footnote F4}	-
Feb 3, 2026	Teena Lerner	Derivative	Stock Option (Right to Buy)	16,500	-^{footnote F4}	-
Footnote F1 (price): Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. ("Purchaser"), Purchaser completed a tender offer for shares of Issuer and thereafter merged… Full note on SEC EDGAR Footnote F2 (price): Pursuant to the Merger Agreement, at the Effective Time, each outstanding RSU (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive the Merger Consideration. Footnote F3 (price): Pursuant to the Merger Agreement, each share of common stock tendered by the Reporting Person was tendered in exchange for the Merger Consideration. Footnote F4 (price): Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a "Stock Option") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an… Full note on SEC EDGAR
Jan 1, 2026	Leslie D. Funtleyder - Officer	Grant or award	Common Stock	150,000	$0.00	-
Dec 16, 2025	Stacy J. Kanter	Open-market sale	Common Stock	43,000	$0.11^{footnote F1}	$5K
Footnote F1 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.1111 to $0.1130. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and… Full note on SEC EDGAR
Oct 1, 2025	Leslie D. Funtleyder - Officer	Grant or award	Common Stock	150,000^{footnote F1}	$0.00	-
Footnote F1 (shares): Consists of compensatory Restricted Stock Units ("RSUs") granted under the Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan (the "Plan"). Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. The compensatory RSUs shall… Full note on SEC EDGAR
Jun 9, 2025	Leslie D. Funtleyder - Officer	Grant or award	Common Stock	150,000	$0.00	-
Jul 1, 2025	Leslie D. Funtleyder - Officer	Grant or award	Common Stock	150,000	$0.00	-
Jun 9, 2025	Jay S. Skyler	Grant or award	Stock Option (Right to Buy)	200,000	$0.00	-
Dec 19, 2024	Leslie D. Funtleyder - Officer	Grant or award	Common Stock	150,000	$0.00	-
Dec 19, 2024	Leslie D. Funtleyder - Officer	Grant or award	Stock Option (Right to Buy)	150,000	$0.00	-
Dec 19, 2024	John Johnson - Officer	Grant or award	Common Stock	500,000	$0.00	-
Dec 19, 2024	John Johnson - Officer	Grant or award	Stock Option (Right to Buy)	1,000,000	$0.00	-

APLT insider trading FAQ

What is the latest insider trade for APLT?

Applied Therapeutics, Inc. (APLT) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-02-04. The full record for APLT runs to 14 Form 4 filings, the earliest from 2024-12-20. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying APLT stock?

No insider purchases of APLT were filed in the last 90 days.

How many insiders are selling APLT stock?

No insider sales of APLT were filed in the last 90 days. 1 sale is on record for this company.

Where can I see APLT SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects APLT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Feb 4, 2026 - Stacy J. Kanter view on EDGAR
Feb 4, 2026 - Corwin Dale Hooks view on EDGAR
Feb 4, 2026 - Constantine Chinoporos view on EDGAR
Feb 3, 2026 - Jay S. Skyler view on EDGAR
Feb 3, 2026 - Leslie D. Funtleyder view on EDGAR
Feb 3, 2026 - Evan Prescott Bailey view on EDGAR
Feb 3, 2026 - Teena Lerner view on EDGAR
Jan 2, 2026 - Leslie D. Funtleyder view on EDGAR
Dec 18, 2025 - Stacy J. Kanter view on EDGAR

Related companies with recent insider activity

Learn more

What the Form 4 transaction codes mean: Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
Insider activity in Health Care: Where APLT's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow APLT with a 7-day demo

APLT on your watchlist
Every APLT Form 4 filing on record
Up to 3 months of APLT price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Date

Insider

Transaction

Security

Price

Value

Feb 3, 2026

Stacy J. Kanter

Derivative

Common Stock

22,500

-^{footnote F1,F2}

Feb 3, 2026

Stacy J. Kanter

Other

Common Stock

42,500

-^{footnote F1,F3}

Feb 3, 2026

Stacy J. Kanter

Derivative

Stock Option (Right to Buy)

20,460

-^{footnote F4}

Feb 3, 2026

Stacy J. Kanter

Derivative

Stock Option (Right to Buy)

10,230

-^{footnote F4}

Feb 3, 2026

Stacy J. Kanter

Derivative

Stock Option (Right to Buy)

16,500

-^{footnote F4}

Feb 3, 2026

Stacy J. Kanter

Derivative

Stock Option (Right to Buy)

16,500

-^{footnote F4}

Feb 3, 2026

Stacy J. Kanter

Derivative

Stock Option (Right to Buy)

200,000

-^{footnote F4}

Footnote F1 (price): Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. ("Purchaser"), Purchaser completed a tender offer for shares of Issuer and thereafter merged… Full note on SEC EDGAR
Footnote F2 (price): Pursuant to the Merger Agreement, at the Effective Time, each outstanding RSU (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive the Merger Consideration.
Footnote F3 (price): Pursuant to the Merger Agreement, each share of common stock tendered by the Reporting Person was tendered in exchange for the Merger Consideration.
Footnote F4 (price): Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a "Stock Option") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an… Full note on SEC EDGAR

Dec 19, 2025

Corwin Dale Hooks - Officer

Grant or award

Common Stock

312,500

$0.00

Feb 3, 2026

Corwin Dale Hooks - Officer

Derivative

Common Stock

862,500

-^{footnote F3,F4}

Feb 3, 2026

Corwin Dale Hooks - Officer

Other

Common Stock

5,753

-^{footnote F5}

Footnote F3 (price): Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. ("Purchaser"), Purchaser completed a tender offer for shares of Issuer and thereafter merged… Full note on SEC EDGAR
Footnote F4 (price): Pursuant to the Merger Agreement, at the Effective Time, each outstanding RSU (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive the Merger Consideration.
Footnote F5 (price): Pursuant to the Merger Agreement, each share of common stock tendered by the Reporting Person was tendered in exchange for the Merger Consideration.

Dec 19, 2025

Constantine Chinoporos - Officer

Grant or award

Common Stock

437,500

$0.00

Feb 3, 2026

Constantine Chinoporos - Officer

Derivative

Common Stock

1,000,000

-^{footnote F3,F4}

Feb 3, 2026

Constantine Chinoporos - Officer

Other

Common Stock

57,111

-^{footnote F5}

Footnote F3 (price): Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. ("Purchaser"), Purchaser completed a tender offer for shares of Issuer and thereafter merged… Full note on SEC EDGAR
Footnote F4 (price): Pursuant to the Merger Agreement, at the Effective Time, each outstanding RSU (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive the Merger Consideration.
Footnote F5 (price): Pursuant to the Merger Agreement, each share of common stock tendered by the Reporting Person was tendered in exchange for the Merger Consideration.

Feb 3, 2026

Jay S. Skyler

Derivative

Stock Option (Right to Buy)

16,500

-^{footnote F4}

Feb 3, 2026

Jay S. Skyler

Derivative

Stock Option (Right to Buy)

16,500

-^{footnote F4}

Feb 3, 2026

Jay S. Skyler

Derivative

Common Stock

22,500

-^{footnote F1,F2}

Feb 3, 2026

Jay S. Skyler

Other

Common Stock

42,500

-^{footnote F1,F3}

Feb 3, 2026

Jay S. Skyler

Derivative

Stock Option (Right to Buy)

20,460

-^{footnote F4}

Feb 3, 2026

Jay S. Skyler

Derivative

Stock Option (Right to Buy)

10,230

-^{footnote F4}

Feb 3, 2026

Jay S. Skyler

Derivative

Stock Option (Right to Buy)

200,000

-^{footnote F4}

Footnote F1 (price): Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. ("Purchaser"), Purchaser completed a tender offer for shares of Issuer and thereafter merged… Full note on SEC EDGAR
Footnote F2 (price): Pursuant to the Merger Agreement, at the Effective Time, each outstanding RSU (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive the Merger Consideration.
Footnote F3 (price): Pursuant to the Merger Agreement, each share of common stock tendered by the Reporting Person was tendered in exchange for the Merger Consideration.
Footnote F4 (price): Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a "Stock Option") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an… Full note on SEC EDGAR

Dec 19, 2025